SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is a major talking point after reporting strong revenue but lowering its profit outlook, partly due to acquisition costs, igniting debate between investors seeing a long-term cybersecurity buying opportunity and those concerned about AI's impact on software valuations.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc (FJET) is trending as its IPO quiet period concludes, driving speculation about potential news such as an FAA Space Launch license. The community is actively discussing the stock's extremely low float and high insider ownership, fueling short squeeze narratives and optimistic price targets amidst broader sector excitement around the upcoming SpaceX IPO.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending amid its new U.S. brewing partnership with Carlsberg and expanded UK pharmaceutical access, while the community is intensely focused on anticipated updates regarding the federal rescheduling of cannabis to Schedule III. Investors are sharply divided between those expecting a significant industry-wide catalyst and critics who highlight Tilray's limited direct benefit from U.S. cannabis reform as a Canadian LP.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is a hot topic after Nvidia's 13F filing revealed it exited its stake in the AI data center provider, fueling debate as optimists view it as old news and smart profit-taking that precedes further hyperscaler contract announcements, while skeptics see a significant loss of confidence.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following conditional marketing authorization for ANKTIVA in Europe, extending its market to 33 countries for hard-to-treat bladder cancer, while high-level discussions in the Middle East signal further global expansion and a broader BioShield Platform. The news has ignited significant community buzz around the company's global reach and humanitarian mission, intensifying expectations of a short squeeze amidst its transformation into a globally validated oncology player.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending after the FDA reversed its earlier decision, agreeing to review the company's modified flu vaccine application. This regulatory shift is driving strong bullish sentiment and short-squeeze speculation among the community, which anticipates significant upside following the prior rejection.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after institutional investors, notably Cormorant Asset Management, significantly increased their position, fueling speculation of a short squeeze. The community is buzzing with excitement over the recent Fast Track designation, upcoming Investor Day, and persistent buyout chatter, believing the stock is undervalued.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is experiencing a dramatic surge with unprecedented trading volume, driven by renewed optimism from its recent earnings call where the CEO expressed confidence in near-term licensing for its MST technology in AI and advanced Gate-All-Around applications. However, community discussions reflect skepticism given the company's long-standing pre-revenue status and historical pattern of unfulfilled promises.

Fiverr International Ltd. develops an e-commerce platform that allows people to buy and sell digital services. It operates through the following geographical segments: U.S., Europe, Asia Pacific, Rest of the World and Israel. The firm offers digital marketing, graphics and design, video and animation, writing and translation, and music and audio. The company was founded by Micha Kaufman and Shai Wininger in 2009 and is headquartered in Tel Aviv, Israel.

Fiverr International Ltd

Fiverr is trending following a significant stock price drop, as weak forward guidance overshadowed its latest earnings and revenue beat; the community is sharply divided between those seeing a deeply undervalued opportunity and those concerned about AI's impact on its gig-economy model.

WorldFinancial

WLFI is trending ahead of a Trump-backed crypto forum at Mar-a-Lago, fueling speculation about institutional adoption and real-world utility for its stablecoin and cross-border payment platform. However, the token also faces significant scrutiny from a House probe into foreign investment ties, leading to a highly polarized community discussion between those expecting major gains and critics calling it a political "scam."

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$EOLS adding a bit and will continue to scale if it goes to lower 4s. If they can hit profitability in ‘26 as they’ve recently claimed this could be a multibagger

StockTwits for iOS

Evolus Inc

 adding a bit and will continue to scale if it goes to lower 4s. If they can hit profitability in ‘26 as they’ve recently claimed this could be a multibagger

Castle Biosciences Inc

Pulmonx Corp

Outset Medical Inc

Inotiv Inc

MaxCyte Inc

RxSight Inc

Satellogic Inc - Ordinary Shares - Class A

Ceribell Inc.

Rocket

@RocketThief Hey Rocket. Mind elevator pitching this Badboy for me? Thank you on behalf of my wife who is curious

 Hey Rocket. Mind elevator pitching this Badboy for me? Thank you on behalf of my wife who is curious

Codexis Inc.

CorMedix Inc

Akebia Therapeutics Inc.

Syndax Pharmaceuticals Inc

Esperion Therapeutics Inc.

Harrow Health Inc

Crinetics Pharmaceuticals Inc

Milestone Pharmaceuticals Inc

Chris Ozolinch

@Bondra this one’s a turnaround play since the company is saying as of only a few days ago that they will be profitable as of early this year.  $305M-ish market cap for ~$332M in guided sales (low teens growth) is a steal if they do indeed hit that promised profitability. Their balance sheet is improving (cash increased as of last quarter) although they do have more debt than I’d like ($145M). I don’t know the aesthetics space very well but I don’t think they would have been so confident about sustained near term profitability in their latest prelim release if they didn’t think they could hit it, so worth a spec at this valuation imo

 this one’s a turnaround play since the company is saying as of only a few days ago that they will be profitable as of early this year.  $305M-ish market cap for ~$332M in guided sales (low teens growth) is a steal if they do indeed hit that promised profitability. Their balance sheet is improving (cash increased as of last quarter) although they do have more debt than I’d like ($145M). I don’t know the aesthetics space very well but I don’t think they would have been so confident about sustained near term profitability in their latest prelim release if they didn’t think they could hit it, so worth a spec at this valuation imo